Stroke Acute Ischemic

• CLINICAL_TRIALS trial_result · 2024-03-05
  Clinical Trial Update: Cerebroprotective Effect of Melatonin in Stroke [Phase 3]

  A Phase 3 trial evaluating melatonin for cerebroprotective effects in acute ischemic stroke is reported as ongoing with unknown status.

• CLINICAL_TRIALS trial_result · 2023-10-16
  Clinical Trial Update: The Effect of Early Administration of PCSK9 Inhibitor to Acute Ischemic Stroke Patients Associated With Atherosclerosis on the Stroke Prognosis and Lipid Profile [Phase 4]

  Phase 4 trial investigating early administration of a PCSK9 inhibitor in acute ischemic stroke patients with atherosclerosis to assess effec…

• CLINICAL_TRIALS trial_result · 2023-06-01
  Clinical Trial Update: A Multicenter Study to Evaluate the Effect of High Dose Rosuvastatin Versus Rosuvastatin and Ezetimibe in Stroke [Phase 4]

  A Phase 4 multicenter clinical trial comparing high-dose rosuvastatin to rosuvastatin with ezetimibe in patients with dyslipidemias and acut…

• CLINICAL_TRIALS trial_result · 2023-02-14
  Clinical Trial Update: Endovascular Thrombectomy With and Without Intravenous Thrombolysis in Extended Time Window [Phase 3]

  Phase 3 trial updating endovascular thrombectomy with and without IV thrombolysis in extended time window for acute ischemic stroke.

• CLINICAL_TRIALS trial_result · 2021-11-17
  Clinical Trial Update: Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT [Phase 2, Phase 3]

  Clinical trial update for early administration of Cerebrolysin in acute ischemic stroke patients undergoing EVT (Phase 2/Phase 3).

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2021-10-25
  Clinical Trial Update: Mechanical Thrombectomy of Medium Sized Vessels "M2 of MCA". [Phase 3]

  Phase 3 clinical trial update on mechanical thrombectomy for medium-sized vessels (M2 of MCA) in acute ischemic stroke.